Prestige Wealth Management Group LLC Acquires 2,216 Shares of UnitedHealth Group Incorporated $UNH

Posted by Geri Gentry on Jun 5th, 2026

Prestige Wealth Management Group LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 83.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 4,873 shares of the healthcare conglomerate’s stock after buying an additional 2,216 shares during the period. Prestige Wealth Management Group LLC’s holdings in UnitedHealth Group were worth $1,609,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Sarver Vrooman Wealth Advisors bought a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $25,000. Beacon Financial Strategies CORP bought a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $26,000. Anfield Capital Management LLC raised its position in shares of UnitedHealth Group by 220.0% during the fourth quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock worth $26,000 after purchasing an additional 55 shares during the period. Joseph Group Capital Management acquired a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $27,000. Finally, Foster Dykema Cabot & Partners LLC raised its position in shares of UnitedHealth Group by 69.4% during the third quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 34 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the company. Wells Fargo & Company upped their target price on UnitedHealth Group from $370.00 to $397.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 22nd. Truist Financial upped their target price on UnitedHealth Group from $395.00 to $440.00 and gave the stock a “buy” rating in a research report on Monday. UBS Group upped their target price on UnitedHealth Group from $410.00 to $460.00 and gave the stock a “buy” rating in a research report on Friday, May 22nd. Weiss Ratings raised UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, May 7th. Finally, Sanford C. Bernstein increased their price target on UnitedHealth Group from $444.00 to $492.00 and gave the company an “outperform” rating in a research report on Wednesday, May 27th. One analyst has rated the stock with a Strong Buy rating, twenty have assigned a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $404.42.

View Our Latest Report on UnitedHealth Group

UnitedHealth Group Trading Up 5.4%

NYSE UNH opened at $397.25 on Friday. The firm has a market capitalization of $360.76 billion, a P/E ratio of 30.00, a PEG ratio of 1.62 and a beta of 0.64. The business has a fifty day simple moving average of $345.52 and a 200 day simple moving average of $323.05. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $404.15. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, beating analysts’ consensus estimates of $6.76 by $0.47. The business had revenue of $111.65 billion during the quarter, compared to analyst estimates of $109.84 billion. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.UnitedHealth Group’s quarterly revenue was up 2.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $7.20 EPS. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 18.29 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th will be paid a $2.32 dividend. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.21. The ex-dividend date is Monday, June 15th. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. UnitedHealth Group’s dividend payout ratio is currently 66.77%.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

Positive Sentiment: Bank of America upgraded UnitedHealth to Buy from Neutral and lifted its price target to $450, citing improving medical cost trends and a better risk/reward setup ahead of earnings. Article Title
Positive Sentiment: Morgan Stanley also raised its price target on UNH to $453 and kept an Overweight rating, reinforcing the view that the stock has room to recover. Article Title
Positive Sentiment: UnitedHealth raised its quarterly dividend by 5% to $2.32 per share, marking its 16th consecutive year of dividend increases and signaling confidence in cash flow despite a tough insurance backdrop. Article Title
Positive Sentiment: Multiple market reports noted that analysts are increasingly optimistic on managed-care names, pointing to softer medical cost and utilization trends that could support earnings recovery for UNH. Article Title
Neutral Sentiment: The company also provided updates on its annual shareholder meeting and board actions, with shareholders re-electing directors and approving executive compensation; these items are routine and do not appear to be the main driver of trading. Article Title
Negative Sentiment: Broader market headlines show weakness in tech stocks and mixed futures, but these macro moves appear to be secondary to the strong company-specific buying in UNH today. Article Title

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of the company’s stock in a transaction on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total value of $284,000.00. Following the completion of the transaction, the chief executive officer owned 17,805 shares in the company, valued at $6,320,775. This represents a 4.30% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.28% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.